MIT’s latest implantable device releasing glucagon automatically when blood sugar drops too low, tested in diabetic mice, ...

As of 2024, Brazil's Semaglutide market was estimated at $581 million. The global market size for the GLP-1 (glucagon-like ...

GLP-1s (glucagon-like peptide-1 receptor agonists), like Wegovy, Ozempic, or generic liraglutide, have helped you reach your ...

Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...

We've got fresh evidence for how weight can quickly be regained after weight-loss programs stop – but rather than looking at ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

The new implant contains a reservoir of glucagon that sits beneath the skin and can be activated in an emergency, with no ...

When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...

Use of glucagon-like peptide-1 receptor agonists might be beneficial for patients with some cancers, research suggests.

New study reveals adding whey protein to dual-source carbohydrates enhances amino acid availability without compromising ...

Mumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (USFDA) ...

IcoSema was associated with significantly improved body weight and glycemic control among patients with inadequately controlled type 2 diabetes.